Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrainline Regulatory News (TRN)

Share Price Information for Trainline (TRN)

Share Price is delayed by 15 minutes
Get Live Data
214.00    -4.40 (-2.01%)
Bid:
214.20
Ask:
214.80
Spread: 0.60 (0.28%)
Market Cap: £755.88m
TRN Live PriceLast checked at - London Stock Exchange

Intraday Trainline Share Chart

Stabilisation Notice

21 Jun 2019 07:06

RNS Number : 0073D
Morgan Stanley & Co. Int'l plc
21 June 2019
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Trainline plc

Stabilisation Notice

21/06/19

Morgan Stanley & Co. International plc (contact: James Manson-Bahr; telephone: +44 20 7425-3672) hereby gives notice, as Stabilisation Manager, that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014.

 

The securities:

Issuer:

Trainline plc

Securities:

Ordinary shares ("Shares") of the Issuer (ISIN: GB00BKDTK925)

Offer size:

271,655,470 ("Offer Shares") (excluding the over-allotment option)

Offer price:

350 pence

Stabilisation:

Stabilising Manager(s):

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA

Stabilisation period expected to start on:

Friday 21st June 2019

Stabilisation period expected to end no later than:

Friday 19th July 2019

Maximum size of over-allotment facility:

Up to 40,748,321 shares

Stabilisation trading venue:

London Stock Exchange

Over-allotment Option:

Terms:

KKR Victoria Aggregator L.P. has granted Morgan Stanley & Co. International plc, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 40,748,321 Shares at the Offer Price (representing up 15 per cent of the Offer size).

Duration:

This option may be executed at any time during the stabilisation period.

 

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

END.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAFBMFTMBMTMJL
Date   Source Headline
20th May 202112:24 pmRNSPublication of Williams-Shapps Plan for UK Rail
14th May 20214:07 pmRNSHolding(s) in Company
6th May 202110:30 amRNSDirector/PDMR Shareholding
6th May 20217:00 amRNSResults for the 12 months ended 28 February 2021
28th Apr 202111:38 amRNSHolding(s) in Company
26th Apr 20213:22 pmRNSHolding(s) in Company
26th Apr 20219:12 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTRADING STATEMENT AND NOTICE OF FY RESULTS
5th Mar 20212:54 pmRNSHolding(s) in Company
25th Feb 202110:00 amRNSCommittee Change
17th Feb 202110:00 amRNSDirector/PDMR Shareholding
12th Jan 20215:11 pmRNSHolding(s) in Company
7th Jan 20216:31 pmRNSReference VWAP for Convertible Bond Offering
7th Jan 20211:40 pmRNSPricing of Convertible Bond Offering
7th Jan 20217:00 amRNSConvertible Bond Offering & Covenant Waiver Ext.
6th Jan 20213:19 pmRNSHolding(s) in Company
30th Dec 20204:31 pmRNSHolding(s) in Company
3rd Dec 202010:00 amRNSDirector/PDMR Shareholding
19th Nov 20203:32 pmRNSHolding(s) in Company
19th Nov 202010:00 amRNSExecutive Director PSP Grant Notification
17th Nov 202012:40 pmRNSDirector Declaration
5th Nov 20207:00 amRNSResults for the six months ended 31 August 2020
30th Oct 20201:53 pmRNSHolding(s) in Company
28th Oct 20204:30 pmRNSHolding(s) in Company
28th Oct 20202:36 pmRNSHolding(s) in Company
27th Oct 20201:58 pmRNSHolding(s) in Company
26th Oct 20202:26 pmRNSHolding(s) in Company
26th Oct 20209:00 amRNSHolding(s) in Company
23rd Oct 20209:16 amRNSHolding(s) in Company
22nd Oct 20209:00 amRNSHolding(s) in Company
21st Oct 20203:51 pmRNSHolding(s) in Company
20th Oct 20207:00 amRNSCEO Succession
28th Sep 20204:43 pmRNSHolding(s) in Company
23rd Sep 202010:36 amRNSHolding(s) in Company
22nd Sep 20203:00 pmRNSDirectorate Change
17th Sep 20207:00 amRNSTRADING STATEMENT AND NOTICE OF HALF YEAR RESULTS
11th Sep 202011:24 amRNSHolding(s) in Company
9th Sep 20201:59 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSDirector/PDMR Shareholding
27th Aug 20204:00 pmRNSDirector Declaration
29th Jul 20205:14 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSAppointment of Chief Operating Officer
6th Jul 20209:02 amRNSHolding(s) in Company
6th Jul 20209:01 amRNSHolding(s) in Company
6th Jul 20209:00 amRNSHolding(s) in Company
25th Jun 20204:00 pmRNSResult of AGM
18th Jun 20209:00 amRNSHolding(s) in Company
11th Jun 20205:18 pmRNSHolding(s) in Company
5th Jun 20209:59 amRNSHolding(s) in Company
2nd Jun 20203:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.